Alector (ALEC) Total Liabilities (2018 - 2026)
Alector's (ALEC) quarterly Total Liabilities came in at $212.8 million in Q2 2026, down 25.39% year-over-year from $285.2 million in Q2 2025, and down 7.28% quarter-over-quarter from $229.5 million in Q1 2026.
Analysis
Alector (ALEC) Total Liabilities (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Total Liabilities for 9 consecutive years, with $212.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Liabilities fell 25.39% year-over-year to $212.8 million in Q2 2026; TTM through Jun 2026 was $212.8 million, a 25.39% decrease from a year earlier, with the FY2025 full-year figure at $262.6 million, down 23.11% from the prior year.
- Total Liabilities was $212.8 million for Q2 2026 at Alector, down from $229.5 million in the prior quarter.
- Over five years, Total Liabilities peaked at $686.9 million in Q1 2022 and troughed at $212.8 million in Q2 2026.
- A 5-year average of $428.7 million and a median of $438.4 million in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities jumped 223.2% in 2022 and slumped 32.11% in 2025, its largest moves.
- Over 5 years, Total Liabilities stood at $573.2 million in 2022, then slipped by 14.92% to $487.7 million in 2023, then declined by 29.97% to $341.5 million in 2024, then retreated by 23.11% to $262.6 million in 2025, then retreated by 18.95% to $212.8 million in 2026.
- The last three Total Liabilities figures came in at $212.8 million (Q2 2026), $229.5 million (Q1 2026), and $262.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 83.95 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 37.53 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 7.18 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 10.02 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 1.62 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 4.20 Bn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 13.24 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 212.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 212.83 Mn |
| Mar 31, 2026 | 229.53 Mn |
| Dec 31, 2025 | 262.59 Mn |
| Sep 30, 2025 | 277.57 Mn |
| Jun 30, 2025 | 285.25 Mn |
| Mar 31, 2025 | 313.69 Mn |
| Dec 31, 2024 | 341.50 Mn |
| Sep 30, 2024 | 397.09 Mn |
| Jun 30, 2024 | 420.16 Mn |
| Mar 31, 2024 | 456.59 Mn |
| Dec 31, 2023 | 487.67 Mn |
| Sep 30, 2023 | 509.84 Mn |
| Jun 30, 2023 | 512.43 Mn |
| Mar 31, 2023 | 565.33 Mn |
| Dec 31, 2022 | 573.21 Mn |
| Sep 30, 2022 | 583.93 Mn |
| Jun 30, 2022 | 601.16 Mn |
| Mar 31, 2022 | 686.92 Mn |
| Dec 31, 2021 | 513.93 Mn |
| Sep 30, 2021 | 518.34 Mn |